Moderna Stocks Soar After Phase-3 Covid Vaccine Trial Begins
Moderna on Sunday announced it had received a commitment of up to $472 million in additional funding from its contract with the Biomedical Advanced Research and Development Authority.The company on Monday announced that participants in the…